Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture

| Importance: 9/10 | Status: confirmed

Dr. Patrizia Cavazzoni, former head of the FDA’s Center for Drug Evaluation and Research (CDER), immediately transitioned to Pfizer as chief medical officer, reigniting intense debate about the pharmaceutical industry’s regulatory influence and the problematic ‘revolving door’ between government agencies and private corporations.

Key Actors

Patrizia Cavazzoni FDA Pfizer Robert F. Kennedy Jr. Center for Drug Evaluation and Research Diana Zuckerman Public Citizen's Health Research Group

Tags

regulatory-capture pharmaceutical-industry fda revolving-door institutional-corruption healthcare-policy executive-transitions

Sources (3)

Help Improve This Timeline

Found an error or have additional information? You can help improve this event.

✏️ Edit This Event ➕ Suggest New Event

Edit: Opens GitHub editor to submit corrections or improvements via pull request.
Suggest: Opens a GitHub issue to propose a new event for the timeline.